PPD opening new Phase I unit in Las Vegas

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/SerrNovik)
(Image: iStock/SerrNovik)
The 24-bed clinical research unit in Las Vegas supports PPD’s Phase I and early development clinical research capabilities.

Cindy Doerfler, vice president of PPD’s early development division told us, “with the opening of this new clinical research unit, PPD is expanding its early development services to support studies involving complex, procedurally intensive early phase clinical research​.”

The operation will support first-in-human through proof-of-concept trials in both healthy and patient volunteers.

Offered services will range from nonclinical consulting to protocol writing, protocol optimization, project management, laboratory services, monitoring, medical writing, data management, biostatistics, and clinical pharmacology.

Location

The company chose Las Vegas for this new unit for several reasons, Doerfler said.

Las Vegas offers logistical and geographic access to the west coast, it is in close proximity to multiple universities—including two medical schools—as well as six local research sites to optimize volunteer recruitment, and its location adjacent to the Dignity Health-St. Rose Dominican, San Martín campus allows us to utilize the facility’s hospital-based services and medical expertise on behalf of our clients​,” she explained.

First studies are expected to commence in the third quarter of 2017.

Related topics: Clinical Development, Phase I-II

Related news

Show more

Related products

VDS groß

Meet the challenges of complex injectables

Vetter Pharma International GmbH | 07-Nov-2017 | Technical / White Paper

In the time it takes from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can...

Related suppliers